Last reviewed · How we verify
Continued Access Arm
At a glance
| Generic name | Continued Access Arm |
|---|---|
| Sponsor | ViiV Healthcare |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) (PHASE2)
- Assisted Identification and Navigation of Early Mental Health Symptoms in Children (NA)
- Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer (NA)
- Implementation Science to Enhance HIV Testing Services During Emergency Care in Kenya (NA)
- Personalised Active Self-management of Sleep Apnea Program (NA)
- MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) (PHASE2)
- AI Tool to Reduce Clinician Documentation Burden (NA)
- Brief Intervention at Adult Education (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |